Transine Therapeutics
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Babraham Hall House, Babraham, Cambridge...Website
www.transinetx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Transine Therapeutics
Founded in 2020, Transine Therapeutics is a biotechnology company based in Cambridge, United Kingdom.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Transine Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Transine Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Transine Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Transine Therapeutics launches new products
Click to see if Transine Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Transine Therapeutics has new funding data
Check out if Transine Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Transine Therapeutics recently announced quarterly report
Check if Transine Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Transine Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Transine Therapeutics
Compare insights from companies similar to Transine Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Transine Therapeutics
<$5M
1-10
Private
$30.1M
2020
N/A
Company Profile Activity
Activity Insights
Transine Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Transine Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Transine Therapeutics.
Transine Therapeutics financials insights
Gather financial insights about Transine Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$12.9M
2022
Angel/Seed
$17.2M
Transine Therapeutics Tech Stack
A closer look at the technologies used by Transine Therapeutics
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Funding
New Hire
Management Move
Madeleine Wakeling has been named Programme Management Head. Previously, Wakeling served as Project Manager, Immunotherapeutics at University College London.
New Hire
Executive Move
Funding
Transine Therapeutics News & Media
Transine Therapeutics Announces Final Closing of its Seed Round at £13.7m to Accelerate its Platform and Portfolio Development
Company adds £4.6m additional seed funding Strengthens investor syndicate with Epidarex joining as a new investor Enhances ability to leverage unique SINEUP® platform and rapidly advance product development programmes CAMBRIDGE, England, May 31, 2022 /PRNewswire/ -- Transine Therapeutics...Transine Therapeutics Appoints Industry Veteran Jan Thirkettle Ph.D. as CEO
CAMBRIDGE, England, July 5, 2021 /PRNewswire/ -- Transine Therapeutics, a biotechnology company developing a novel class of therapeutic RNAs based on its pioneering SINEUP® platform technology, today announced the appointment of Jan Thirkettle, Ph.D. as its Chief Executive Officer. He...Transine Therapeutics' £9.1m will drive forward RNA therapeutics
Seed round for Babraham-based company puts key cellular regulators into treatment spotlightTransine Therapeutics Raises £9.1 in Funding
Transine Therapeutics, a Cambridge UK-based biotechnology company which specializes in development of therapeutic RNAs, closed £9.1 in funding. The round was led by Takeda Ventures, Inc. and the Dementia Discovery Fund (DDF). In conjunction with the financing, Rob Woodman, Senior Partner at Takeda Ventures, and Christian Jung, Partner at the DDF joined Transine’s Board. The company intends […] The post Transine Therapeutics Raises £9.1 in Funding appeared first on FinSMEs.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Transine Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 2020, Transine Therapeutics is a biotechnology company based in Cambridge, United Kingdom.... Read More
